JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 40 No. 1 184-191
© 1999 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blankenberg, F. G.
Right arrow Articles by Strauss, H.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blankenberg, F. G.
Right arrow Articles by Strauss, H.W.

Imaging of Apoptosis (Programmed Cell Death) with 99mTc Annexin V

Francis G. Blankenberg, Peter D. Katsikis, Jonathan F. Tait, R. Eric Davis, Louis Naumovski, Katsuichi Ohtsuki, Susan Kopiwoda, Michael J. Abrams and H.W. Strauss

Departments of Radiology, Genetics, Pathology and Pediatrics (Hematology/Oncology), Stanford University School of Medicine, Stanford, California
Department of Laboratory Medicine, University of Washington, Seattle, Washington
Anor MED, Inc., Langley, British Columbia, Canada

Correspondence: For correspondence or reprints contact: Francis G. Blankenberg, MD, Department of Radiology (Pediatric Radiology), Stanford University School of Medicine, 300 Pasteur Dr., Stanford, CA 94305.

ABSTRACT

Apoptosis (programmed cell death) is a critical element in normal physiology and in many disease processes. Phosphatidylserine (PS), one component of cell membrane phospholipids, is normally confined to the inner leaflet of the plasma membrane. Early in the course of apoptosis, this phospholipid is rapidly exposed on the cell's outer surface. Annexin V, an endogenous human protein, has a high affinity for membrane-bound PS. This protein has been labeled with fluorescein and has been used to detect apoptosis in vitro. We describe the use of radiolabeled annexin V to detect apoptosis in vivo. The results are compared to histologic and flow cytometric methods to identify cells and tissues undergoing apoptosis. Methods: Annexin V was coupled to hydrazinonicotinamide (HYNIC) and radiolabeled with 99mTc. Bioreactivity of 99mTc-HYNIC annexin V was compared with fluorescein isothiocyanate (FITC)-labeled annexin V in cultures of Jurkat T-cell lymphoblasts and in ex vivo thymic cell suspensions undergoing apoptosis in response to different stimuli. In addition, the uptake of FITC annexin V and 99mTc-HYNIC annexin V was studied in heat-treated necrotic Jurkat T-cell cultures. In vivo localization of annexin V was studied in Balb/c mice injected with 99mTc-HYNIC annexin V before and after induction of Fas-mediated hepatocyte apoptosis with intravenously administered antiFas antibody. Results: Membrane-bound radiolabeled annexin V activity linearly correlated to total fluorescence as observed by FITC annexin V flow cytometry in Jurkat T-cell cultures induced to undergo apoptosis in response to growth factor deprivation (N = 10, r2 = 0.987), antiFas antibody (N = 8, r2 = 0.836) and doxorubicin (N = 10, r2 = 0.804); and in ex vivo experiments on thymic cell suspensions with dexamethasone-induced apoptosis from Balb/c mice (N = 6, r2 = 0.989). Necrotic Jurkat T-cell cultures also demonstrated marked increases in radiopharmaceutical (4000–5000-fold) above control values. AntiFas antibody-treated Balb/c mice (N = 6) demonstrated a three-fold rise in hepatic uptake of annexin V (P < 0.0005) above control (N = 10), identified both by imaging and scintillation well counting. The increase in hepatic uptake in antiFas antibody-treated mice correlated to histologic evidence of fulminant hepatic apoptosis. Conclusion: These data suggest that 99mTc-HYNIC annexin V can be used to image apoptotic and necrotic cell death in vivo.

Key Words: annexin V • apoptosis • 99mTc • hydrazinonicotinamide




This article has been cited by other articles:


Home page
 CirculationHome page
F. Rouzet, M. D. Hernandez, F. Hervatin, L. Sarda-Mantel, A. Lefort, X. Duval, L. Louedec, B. Fantin, D. Le Guludec, and J.-B. Michel
Technetium 99m-Labeled Annexin V Scintigraphy of Platelet Activation in Vegetations of Experimental Endocarditis
Circulation, February 12, 2008; 117(6): 781 - 789.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. Taki, T. Higuchi, A. Kawashima, M. Fukuoka, D. Kayano, J. F. Tait, I. Matsunari, K. Nakajima, S. Kinuya, and H. W. Strauss
Effect of Postconditioning on Myocardial 99mTc-Annexin-V Uptake: Comparison with Ischemic Preconditioning and Caspase Inhibitor Treatment
J. Nucl. Med., August 1, 2007; 48(8): 1301 - 1307.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. A. Mankoff, J. F. Eary, J. M. Link, M. Muzi, J. G. Rajendran, A. M. Spence, and K. A. Krohn
Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
Clin. Cancer Res., June 15, 2007; 13(12): 3460 - 3469.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
B. L.J.H. Kietselaer, C. P.M. Reutelingsperger, H. H. Boersma, G. A.K. Heidendal, I. H. Liem, H. J.G.M. Crijns, J. Narula, and L. Hofstra
Noninvasive Detection of Programmed Cell Loss with 99mTc-Labeled Annexin A5 in Heart Failure
J. Nucl. Med., April 1, 2007; 48(4): 562 - 567.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
J. M H Van den Brande, T. C Koehler, Z. Zelinkova, R. J Bennink, A. A te Velde, F. J W ten Cate, S. J H van Deventer, M. P Peppelenbosch, and D. W Hommes
Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease
Gut, April 1, 2007; 56(4): 509 - 517.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. F. Tait, C. Smith, Z. Levashova, B. Patel, F. G. Blankenberg, and J.-L. Vanderheyden
Improved Detection of Cell Death In Vivo with Annexin V Radiolabeled by Site-Specific Methods
J. Nucl. Med., September 1, 2006; 47(9): 1546 - 1553.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. Sarda-Mantel, M. Coutard, F. Rouzet, O. Raguin, J.-M. Vrigneaud, F. Hervatin, G. Martet, Z. Touat, P. Merlet, D. Le Guludec, et al.
99mTc-Annexin-V Functional Imaging of Luminal Thrombus Activity in Abdominal Aortic Aneurysms
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2153 - 2159.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
C. Laumonier, J. Segers, S. Laurent, A. Michel, F. Coppee, A. Belayew, L. V. Elst, and R. N. Muller
A New Peptidic Vector for Molecular Imaging of Apoptosis, Identified by Phage Display Technology
J Biomol Screen, August 1, 2006; 11(5): 537 - 545.
[Abstract] [PDF]

Home page
 JNMHome page
P. D. Acton
Dynamic Imaging of Transient Metabolic Processes: PDT Is Just the Beginning
J. Nucl. Med., July 1, 2006; 47(7): 1067 - 1069.
[Full Text] [PDF]

Home page
 JNMHome page
L. L. Johnson, L. Schofield, T. Donahay, N. Narula, and J. Narula
99mTc-Annexin V Imaging for In Vivo Detection of Atherosclerotic Lesions in Porcine Coronary Arteries
J. Nucl. Med., July 1, 2005; 46(7): 1186 - 1193.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. F. Tait, C. Smith, and F. G. Blankenberg
Structural Requirements for In Vivo Detection of Cell Death with 99mTc-Annexin V
J. Nucl. Med., May 1, 2005; 46(5): 807 - 815.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K. J. Yagle, J. F. Eary, J. F. Tait, J. R. Grierson, J. M. Link, B. Lewellen, D. F. Gibson, and K. A. Krohn
Evaluation of 18F-Annexin V as a PET Imaging Agent in an Animal Model of Apoptosis
J. Nucl. Med., April 1, 2005; 46(4): 658 - 666.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Kenis, H. van Genderen, A. Bennaghmouch, H. A. Rinia, P. Frederik, J. Narula, L. Hofstra, and C. P. M. Reutelingsperger
Cell Surface-expressed Phosphatidylserine and Annexin A5 Open a Novel Portal of Cell Entry
J. Biol. Chem., December 10, 2004; 279(50): 52623 - 52629.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Takei, Y. Kuge, S. Zhao, M. Sato, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki
Time Course of Apoptotic Tumor Response After a Single Dose of Chemotherapy: Comparison with 99mTc-Annexin V Uptake and Histologic Findings in an Experimental Model
J. Nucl. Med., December 1, 2004; 45(12): 2083 - 2087.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. Taki, T. Higuchi, A. Kawashima, J. F. Tait, S. Kinuya, A. Muramori, I. Matsunari, K. Nakajima, N. Tonami, and H. W. Strauss
Detection of Cardiomyocyte Death in a Rat Model of Ischemia and Reperfusion Using 99mTc-Labeled Annexin V
J. Nucl. Med., September 1, 2004; 45(9): 1536 - 1541.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
C. Peker, L. Sarda-Mantel, P. Loiseau, F. Rouzet, L. Nazneen, G. Martet, J.-M. Vrigneaud, A. Meulemans, G. Saumon, J.-B. Michel, et al.
Imaging Apoptosis with 99mTc-Annexin-V in Experimental Subacute Myocarditis
J. Nucl. Med., June 1, 2004; 45(6): 1081 - 1086.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. J. Bennink, M. J. van den Hoff, F. J. van Hemert, K. M. de Bruin, A. L. Spijkerboer, J.-L. Vanderheyden, N. Steinmetz, and B. L. van Eck-Smit
Annexin V Imaging of Acute Doxorubicin Cardiotoxicity (Apoptosis) in Rats
J. Nucl. Med., May 1, 2004; 45(5): 842 - 848.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. T. Macgregor
Biomarkers of Cancer Risk and Therapeutic Benefit: New Technologies, New Opportunities, and Some Challenges
Toxicol Pathol, January 1, 2004; 32(1_suppl): 99 - 105.
[Abstract] [PDF]

Home page
 JNMHome page
S. H. Britz-Cunningham and S. J. Adelstein
Molecular Targeting with Radionuclides: State of the Science
J. Nucl. Med., December 1, 2003; 44(12): 1945 - 1961.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. T. MacGregor
The Future of Regulatory Toxicology: Impact of the Biotechnology Revolution
Toxicol. Sci., October 1, 2003; 75(2): 236 - 248.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
G. J. Kemerink, X. Liu, D. Kieffer, S. Ceyssens, L. Mortelmans, A. M. Verbruggen, N. D. Steinmetz, J.-L. Vanderheyden, A. M. Green, and K. Verbeke
Safety, Biodistribution, and Dosimetry of 99mTc-HYNIC-Annexin V, a Novel Human Recombinant Annexin V for Human Application
J. Nucl. Med., June 1, 2003; 44(6): 947 - 952.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Mochizuki, Y. Kuge, S. Zhao, E. Tsukamoto, M. Hosokawa, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki
Detection of Apoptotic Tumor Response In Vivo After a Single Dose of Chemotherapy with 99mTc-Annexin V
J. Nucl. Med., January 1, 2003; 44(1): 92 - 97.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
A. M. Post, P. D. Katsikis, J. F. Tait, S. M. Geaghan, H. W. Strauss, and F. G. Blankenberg
Imaging Cell Death with Radiolabeled Annexin V in an Experimental Model of Rheumatoid Arthritis
J. Nucl. Med., October 1, 2002; 43(10): 1359 - 1365.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. W. Vannier
Imaging Apoptosis in Rheumatoid Arthritis
J. Nucl. Med., October 1, 2002; 43(10): 1366 - 1367.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Belhocine, N. Steinmetz, R. Hustinx, P. Bartsch, G. Jerusalem, L. Seidel, P. Rigo, and A. Green
Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis
Clin. Cancer Res., September 1, 2002; 8(9): 2766 - 2774.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. Russell, J. A. O'Donoghue, R. Finn, J. Koziorowski, S. Ruan, J. L. Humm, and C. C. Ling
Iodination of Annexin V for Imaging Apoptosis
J. Nucl. Med., May 1, 2002; 43(5): 671 - 677.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
M. Schwaiger
Future perspectives and conclusions
Eur. Heart J. Suppl., September 1, 2001; 3(suppl_F): F19 - F21.
[Abstract] [PDF]

Home page
 JNMHome page
F. G. Blankenberg, L. Naumovski, J. F. Tait, A. M. Post, and H. W. Strauss
Imaging Cyclophosphamide-Induced Intramedullary Apoptosis in Rats Using 99mTc-Radiolabeled Annexin V
J. Nucl. Med., February 1, 2001; 42(2): 309 - 316.
[Abstract] [Full Text]

Home page
 JNMHome page
G. J. Kemerink, I. H. Liem, L. Hofstra, H. H. Boersma, W. C.A.M. Buijs, C. P.M. Reutelingsperger, and G. A.K. Heidendal
Patient Dosimetry of Intravenously Administered 99mTc-Annexin V
J. Nucl. Med., February 1, 2001; 42(2): 382 - 387.
[Abstract] [Full Text]

Home page
 NeoReviewsHome page
C. H. Contag, S. Fraser, and R. Weissleder
Strategies in In Vivo Molecular Imaging
NeoReviews, December 1, 2000; 1(12): e225 - 232.
[Full Text]

Home page
 NeoReviewsHome page
C. H. Contag, R. Weissleder, M. H. Bachmann, and S. E. Fraser
Applications of In Vivo Molecular Imaging in Biology and Medicine
NeoReviews, December 1, 2000; 1(12): e233 - 240.
[Full Text]

Home page
 StrokeHome page
H. D'Arceuil, W. Rhine, A. de Crespigny, M. Yenari, J. F. Tait, W. H. Strauss, T. Engelhorn, A. Kastrup, M. Moseley, F. G. Blankenberg, et al.
99mTc Annexin V Imaging of Neonatal Hypoxic Brain Injury Editorial Comment
Stroke, November 1, 2000; 31(11): 2692 - 2700.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. G. Blankenberg, R. C. Robbins, J. H. Stoot, P. W. Vriens, G. J. Berry, J. F. Tait, and H. W. Strauss
Radionuclide Imaging of Acute Lung Transplant Rejection With Annexin V
Chest, March 1, 2000; 117(3): 834 - 840.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
Y. Ogura, S. M. Krams, O. M. Martinez, S. Kopiwoda, J. P. T. Higgins, C. O. Esquivel, H. W. Strauss, J. F. Tait, and F. G. Blankenberg
Radiolabeled Annexin V Imaging: Diagnosis of Allograft Rejection in an Experimental Rodent Model of Liver Transplantation
Radiology, March 1, 2000; 214(3): 795 - 800.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1999 by the Society of Nuclear Medicine.